Dr. Gregg Kokame, clinical professor of ophthalmology at the University of Hawaii School of Medicine, discusses the benefits of Eylea (aflibercept) compared with other anti-VEGF drugs, as well as late-stage trials for diabetic macular edema and reports of sterile intraocular inflammation following Eylea injections.